Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma

BACKGROUND: The effectiveness of second‐line palliative chemotherapy in patients with recurrent/metastatic osteosarcoma is not well defined. Several small studies (6–19 patients) have reported on ifosfamide as second‐line treatment. In this study we report our single‐center experience with second‐li...

Descripción completa

Detalles Bibliográficos
Autores principales: Verschoor, Arie Jan, Speetjens, Frank M., Dijkstra, P.D. Sander, Fiocco, Marta, van de Sande, Michiel A.J., Bovée, Judith V.M.G., Gelderblom, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Sarcomas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160412/
https://www.ncbi.nlm.nih.gov/pubmed/32297446
http://dx.doi.org/10.1634/theoncologist.2019-0528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160412/
https://www.ncbi.nlm.nih.gov/pubmed/32297446
http://dx.doi.org/10.1634/theoncologist.2019-0528

Ejemplares similares